Diabetes treatment developer Lumena Pharmaceuticals has secured the $2 million it needs to start clinical trials and a little bit extra for good measure. The company’s first round of investment was oversubscribed and led to a haul of $2.5 million, according to amended filings made with the U.S. Securities and Exchange Commission. Lumena’s investors are venture [...]

...(Read whole news on source site)